Tag Archives: T1D

Two Startups Bringing Health Innovation to Vulnerable Communities



Because of the nature of the work we do at StartUp Health, we’re often dealing with bleeding-edge ideas and technologies. Just last week on the show we talked to a founder creating what could be the smallest implantable devices on the market. Others are working on molecules that could cure diseases.

But there’s another kind of innovation that we’re equally passionate about at StartUp Health. That’s the kind of business model innovation that brings the best care and technology already available to new places and new people. There are many vulnerable communities that don’t get to benefit from the latest technical advances and it takes creative founders to bridge the gap.

Today on the podcast we’re highlighting two such founders. The first is Shruti Gurudanti, the CEO & Co-founder of Televëda – a member of the StartUp Health community since 2021. Gurudanti and her team are working with Native American veterans with the goal of lowering rates of suicide and suicidal ideation. They’ve got a tech platform that enables community building and telemedicine-style services, but what Gurudanti has found is that sometimes the most meaningful change is something basic: building trust with communities, particularly those long ignored.

After the conversation with Gurudanti we’ll hear from Kehlin Swain, CEO & Co-founder of Greens by Xplosion Technology, a member of the StartUp Health T1D Moonshot Community. Greens is an app designed to help vulnerable communities – particularly Black and Brown communities in the American South – manage diabetes in a culturally competent way. The app is called “Greens” in honor of one of the biggest cultural disconnects a family member faced as he navigated changing his diet after a diabetes diagnosis.

The common thread between Gurudanti and Swain is using the best tech of today to meet people where they are and to really understand what’s holding them back. Sometimes it’s something basic, like improving internet access or tech literacy, or bringing basic accountability to disease management.

Let’s get into the interviews, recorded live at a recent health tech conference.

 



Innovating in Alzheimer’s disease? Learn how you can join our new Alzheimer’s Moonshot.
Passionate about Type 1 diabetes? Learn how you can get one of the last spots in our T1D Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion


Mission Aligned: Helmsley Charitable Trust and StartUp Health on T1D Moonshot



Welcome back to StartUp Health NOW, the podcast where we hear directly from the entrepreneurs and innovators who are transforming health.

Typically on this show we talk to founders of startups. We’re all about understanding what’s new and next in health, and that often means talking to the people who are in the early days of creating a product or business. Most early-stage startups – healthcare or otherwise – have one thing in common. They need money. It takes a long time to get a healthcare business profitable, and so founders need outside funds to get an idea off the ground, complete their research, or scale up.

That brings us to this week’s guest, David Panzirer, Trustee at the Helmsley Charitable Trust. To put it in simple startup terms, David is a funder. The Helmsley Charitable Trust is an $8 billion dollar philanthropy renowned for its work funding healthcare research and innovative programs.

Of course David’s a lot more than a funder. He’s a father, for one thing, a fact that’s driven his work more than anything else. David’s also a firebrand and an instigator in an industry that often needs a little push in the right direction.

The reason for our interview, which took place at a recent health tech event, is that the Helmsley Charitable Trust has been the anchor partner for StartUp Health’s Type 1 Diabetes Moonshot, and David has been instrumental in getting that effort off the ground. He’s been part of our T1D Impact Board and has met with founders on multiple occasions to give them invaluable feedback and advice.

In this episode, we talk about the wild west of conversational AI, promising new T1D therapeutics, rural medicine, and why Helmsley has positioned itself as a high risk/high reward funder.

Let’s get into it.



Passionate about Type 1 diabetes? Contact us to learn how you can join our T1D Moonshot.
Innovating in Alzheimer’s disease? Contact us to learn how you can join our Alzheimer’s Moonshot.

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

FundersBecome a Health Moonshot Champion

 

 


Gamification in Healthcare: How Two Founders Are Using Games to Heal



This week, we’re talking about gamification in healthcare. Gamification has been a popular buzzword in tech and in health, but it just means using elements we associate with games in non-game contexts. It means capitalizing on the motivations we find in games through things like progress updates and level-up badges to change behaviors and get us to do things that are going to be good for our health.

Today on the show, we’re talking to two founders who are gamifying the healthcare experience in two unique ways.

The first conversation is with Raj Amin, CEO & Co-founder of Arcade Therapeutics, a company that has been in the StartUp Health community since TK. They are a science-first game studio developing games that act like medicine, focusing on mental health. We’ll hear exactly what they’re building and why clinical research is key to their approach.

Then we’ll hear from Farhaneh Ahmadi, PhD, CEO & Co-founder of eddii, a company that is part of our T1D Moonshot. She and her team are using mobile gaming elements to help young people with their Type 1 diabetes management. Her company uses a character named eddii that talks to the user, tells them stories, and plays games with them – making it more relatable and more enjoyable to manage diabetes.

Listen in to learn more about these innovative approaches to improving health.

 


FundersBecome a Health Moonshot Champion

Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Innovating in Alzheimer’s disease? Contact us to learn how you can join our Alzheimer’s Moonshot.
Passionate about Type 1 diabetes? Contact us to learn how you can join our T1D Moonshot.
Looking to break down health barriers? Contact us to learn how you can join our Health Equity Moonshot
.


Why the CEO of the American Diabetes Association (ADA) Joined StartUp Health’s Health Moonshot Impact Board



Since 2020, Charles “Chuck” Henderson has led the American Diabetes Association (ADA) as CEO. In 2023, he joined StartUp Health’s Health Moonshot Impact Board, a unique, multi-disciplinary group of stakeholders passionate about advancing health innovation. On the Health Moonshot Impact Board, Henderson joins top thought leaders like Dr. Toby Cosgrove (former CEO, Cleveland Clinic) and Sue Siegel (former CEO, GE Ventures).

In this StartUp Health NOW episode, StartUp Health’s Logan Plaster sat down with Henderson to learn about his priorities in leading the ADA and why it was important to him to join StartUp Health’s moonshot community.


FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


How GO-Pen’s “Insulin Pen for All” Is Making High-Quality T1D Care Globally Accessible



Our StartUp Health NOW guest this week is Ole Kjerkegaard Nielsen, PhD, CEO & Co-founder of GO-Pen, a company in our Type 1 Diabetes Moonshot community.

As you’ll hear, Nielsen and his team based in Denmark have built a new kind of insulin pen, one that is affordable and accessible to all while also adhering to the absolute highest standards of quality. This more accessible insulin pen could change millions of people’s lives.

We’ll also get a glimpse into the uniquely challenging startup journey of developing a physical medical device. Nielsen and his team have been winning awards and grants on a regular basis, but the road is still steep. Whether it’s negotiating with a manufacturer across the globe or getting FDA approval, bringing a medical device to market as a startup with limited funds is a challenge that could intimidate even the most market-tested CEOs. Nielsen pulls back the curtain and lets us see that challenge from the inside and shows us where GO-Pen is going next.

Enjoy!


FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


From the Archives: Aaron Kowalski, PhD, CEO of JDRF, Brings His Professional & Personal Experience to StartUp Health’s T1D Moonshot Impact Board



For this StartUp Health NOW episode, we are taking a look back at a great episode featuring Aaron Kowalski, PhD, the CEO of JDRF International. Anyone orbiting in the universe of Type 1 diabetes knows that JDRF is the world’s largest nonprofit funder of T1D research. In his role atop the organization, Kowalski has combined his professional experience as a molecular biologist and executive with his personal passion to fight Type 1 diabetes in order to impact patients like his own brother.

Kowalski is also an exciting addition to StartUp Health’s Type 1 Diabetes Moonshot Impact Board. This board is a cross-disciplinary team of T1D experts spanning the gamut from research to funding to commercialization. We are thrilled that Kowalski is bringing his vast experience to this community in order to speed up innovation and support a generation of health entrepreneurs.

We will be back with fresh episodes after Labor Day!


 

FundersBecome a Health Moonshot Champion
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.
Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.


Aaron Kowalski, PhD, CEO of JDRF, Brings His Professional & Personal Experience to StartUp Health’s T1D Moonshot Impact Board



For this StartUp Health NOW episode, we are joined by Aaron Kowalski, PhD, the CEO of JDRF International. Anyone orbiting in the universe of Type 1 diabetes will know that JDRF is the world’s largest nonprofit funder of T1D research. In his role atop the organization, Kowalski has combined his professional experience as a molecular biologist and executive with his personal passion to fight Type 1 diabetes in order to impact patients like his own brother.

Kowalski is also a recent addition to StartUp Health’s Type 1 Diabetes Moonshot Impact Board. This board is a cross-disciplinary team of T1D experts spanning the gamut from research to funding to commercialization. We are thrilled that Kowalski is bringing his vast experience to this cohort in order to speed up innovation and support a generation of health entrepreneurs.

Join us at the StartUp Health Festival @ HLTH, Nov 13-16 in Las Vegas, to learn more and get involved with our T1D Moonshot.


Entrepreneurs: How to get investment from StartUp Health startuphealth.com

Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Passionate about Type 1 diabetes? If you’re an entrepreneur or investor, contact us to learn how you can join our T1D Moonshot.
Looking to break down health barriers? If you’re an entrepreneur or investor, contact us to learn how you can join our Health Equity Moonshot.

David Weingard Breaks Down the Mission and Vision of StartUp Health’s New T1D Moonshot



This week’s episode is a conversation with a very special guest, David Weingard. For years StartUp Health backed his work as a founder as he built up a startup called Cecelia Health that provides a combination of high-tech and high-touch care for people with diabetes. Now David is leading a new initiative here at StartUp Health, the Type 1 Diabetes Moonshot. As the Chief Impact Officer, David has brought together an all-star team of T1D advocates to further this moonshot by onboarding investors, entrepreneurs, and researchers who are building the future of health. Hear how the Type 1 Diabetes Moonshot Impact Board is breaking down silos and speeding up innovation — and how you can join the effort.


 

Entrepreneurs, are you working on a T1D solution? We want to hear from you.
Investors, want to back an impact-driven fund laser focused on T1D? Contact us.

Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.